48 related articles for article (PubMed ID: 1670949)
1. The Molecular Mechanisms of Complement Receptor 1-It Is Complicated.
Hardy MP; Mansour M; Rowe T; Wymann S
Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892204
[TBL] [Abstract][Full Text] [Related]
2. Circulating Immune Complex Levels are Associated with Disease Severity and Seasonality in Children with Malaria from Mali.
Thomas BN; Diallo DA; Noumsi GT; Moulds JM
Biomark Insights; 2012; 7():81-6. PubMed ID: 22837639
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites.
Brouwers N; Van Cauwenberghe C; Engelborghs S; Lambert JC; Bettens K; Le Bastard N; Pasquier F; Montoya AG; Peeters K; Mattheijssens M; Vandenberghe R; Deyn PP; Cruts M; Amouyel P; Sleegers K; Van Broeckhoven C
Mol Psychiatry; 2012 Feb; 17(2):223-33. PubMed ID: 21403675
[TBL] [Abstract][Full Text] [Related]
4. Antibody CR1-2B11 recognizes a non-polymorphic epitope of human CR1 (CD35).
Chen CH; Ghiran I; Beurskens FJ; Weaver G; Vincent JA; Nicholson-Weller A; Klickstein LB
Clin Exp Immunol; 2007 Jun; 148(3):546-54. PubMed ID: 17493021
[TBL] [Abstract][Full Text] [Related]
5. A polymorphism in the type one complement receptor (CR1) involves an additional cysteine within the C3b/C4b binding domain that inhibits ligand binding.
Birmingham DJ; Irshaid F; Gavit KF; Nagaraja HN; Yu CY; Rovin BH; Hebert LA
Mol Immunol; 2007 Jul; 44(14):3510-6. PubMed ID: 17467802
[TBL] [Abstract][Full Text] [Related]
6. Direct and regulated interaction of integrin alphaEbeta7 with E-cadherin.
Higgins JM; Mandlebrot DA; Shaw SK; Russell GJ; Murphy EA; Chen YT; Nelson WJ; Parker CM; Brenner MB
J Cell Biol; 1998 Jan; 140(1):197-210. PubMed ID: 9425167
[TBL] [Abstract][Full Text] [Related]
7. Herpes simplex virus glycoprotein C: molecular mimicry of complement regulatory proteins by a viral protein.
Huemer HP; Wang Y; Garred P; Koistinen V; Oppermann S
Immunology; 1993 Aug; 79(4):639-47. PubMed ID: 8406590
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic uses of recombinant complement protein inhibitors.
Kalli KR; Hsu P; Fearon DT
Springer Semin Immunopathol; 1994; 15(4):417-31. PubMed ID: 8153875
[TBL] [Abstract][Full Text] [Related]
9. Complement deficiency and immune complex disease.
Davies KA; Schifferli JA; Walport MJ
Springer Semin Immunopathol; 1994; 15(4):397-416. PubMed ID: 8153874
[No Abstract] [Full Text] [Related]
10. Increased frequency of the long (S) allotype of CR1 (the C3b/C4b receptor, CD35) in patients with systemic lupus erythematosus.
Cornillet P; Gredy P; Pennaforte JL; Meyer O; Kazatchkine MD; Cohen JH
Clin Exp Immunol; 1992 Jul; 89(1):22-5. PubMed ID: 1352746
[TBL] [Abstract][Full Text] [Related]
11. Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis.
Klickstein LB; Bartow TJ; Miletic V; Rabson LD; Smith JA; Fearon DT
J Exp Med; 1988 Nov; 168(5):1699-717. PubMed ID: 2972794
[TBL] [Abstract][Full Text] [Related]
12. Structure-function relationships of complement receptor type 1.
Krych-Goldberg M; Atkinson JP
Immunol Rev; 2001 Apr; 180():112-22. PubMed ID: 11414353
[TBL] [Abstract][Full Text] [Related]
13. Structural and functional correlation of the human complement receptor type 1.
Wong WW
J Invest Dermatol; 1990 Jun; 94(6 Suppl):64S-67S. PubMed ID: 2141049
[TBL] [Abstract][Full Text] [Related]
14. Proposed structure of the F' allotype of human CR1. Loss of a C3b binding site may be associated with altered function.
Wong WW; Farrell SA
J Immunol; 1991 Jan; 146(2):656-62. PubMed ID: 1670949
[TBL] [Abstract][Full Text] [Related]
15. A soluble deletion mutant of the human complement receptor type 1, which lacks the C4b binding site, is a selective inhibitor of the alternative complement pathway.
Scesney SM; Makrides SC; Gosselin ML; Ford PJ; Andrews BM; Hayman EG; Marsh HC
Eur J Immunol; 1996 Aug; 26(8):1729-35. PubMed ID: 8765013
[TBL] [Abstract][Full Text] [Related]
16. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
Fischer E; Kazatchkine MD; Mecarelli-Halbwachs L
Eur J Immunol; 1984 Dec; 14(12):1111-4. PubMed ID: 6240408
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
